Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Freeline Therapeutics
(FRLN) Q3 2023
Earnings
FRLN
Dec 22
Expected
Nov 2022
Q4 2022
Q2 2023
Q3 2023
-2.76
-1.84
-0.92
0
Details
Expected EPS
-0.23
Actual EPS
-2.7577
Surprise EPS
-2.53
Surprise Percent
-1,099%
Description
Freeline Therapeutics (FRLN) has reported earnings of -2.7577 per share for Q3 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login